Eyepoint Pharmaceuticals Inc (EYPT)
Healthcare
Biotechnology
12.30 $
-4.7%
vs. previous close
Closing price · As of: 31. Jul 2026
Eyepoint Pharmaceuticals Inc (EYPT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -81 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 57 | -15 | -23 | -31 | -20 | -39 | -36 | -53 | -63 | -59 | -65 | -81 | -268 | |
| 0.1 | 0.1 | 0.1 | 0.3 | 0.4 | 0.4 | 0.5 | 0.5 | 0.5 | 0.6 | 0.7 | 0.6 | 2.4 | |
| 1.8 | 3.6 | 3.6 | 13 | 8.7 | 7.4 | 7.9 | 7.8 | 6.9 | 6.4 | 6.7 | 12 | 32 | |
| 3.8 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 76 | -6.3 | -12 | -14 | 3.3 | 11 | -1.1 | -15 | -9.3 | -5.7 | -4.3 | -7.2 | -26 | |
| 0.4 | 1.7 | 0.9 | 1.2 | 0.9 | 1.6 | 0.4 | 0.3 | 1.2 | 0.8 | 1.0 | 1.0 | 4.0 | |
| 13 | -1.7 | -47 | 21 | -160 | 16 | -96 | 40 | 48 | 55 | -75 | 59 | 88 | |
| 0.0 | – | – | -4.4 | -0.1 | -0.1 | – | – | – | – | – | – | – | |
| -37 | – | – | – | – | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | |
| -37 | 10 | 218 | 0.1 | 0.3 | 12 | 152 | -1.0 | 0.2 | 7.4 | 167 | -2.6 | 172 | |
| 34 | -6.6 | 148 | -10 | -180 | -11 | 20 | -15 | -14 | 3.4 | 27 | -24 | -7.4 | |
| 57 | -17 | -24 | -32 | -21 | -41 | -36 | -53 | -64 | -60 | -66 | -82 | -272 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.